key: cord-0905062-1uyx1e1x
authors: Flor, N.; Casazza, G.; Saggiante, L.; Savoldi, A. P.; Vitale, R.; Villa, P.; Martucci, F.; Ballone, E.; Castelli, A.; Brambilla, A. M.
title: Chest radiography predictor of COVID-19 adverse outcomes. A lesson learnt from the first wave
date: 2021-03-31
journal: Clin Radiol
DOI: 10.1016/j.crad.2021.03.011
sha: d6bd1e08423447c1d4fc1be86e2b615d61a2e591
doc_id: 905062
cord_uid: 1uyx1e1x

Aim To assess the role of a severity score based on chest radiography (CXR) in predicting the risk of adverse outcomes in coronavirus disease 2019 (COVID-19). Materials and methods Of the patients who presented to Hospital between 21 February and 31 March 2020, patients with a laboratory confirmation of COVID-19 who also underwent a CXR were included in the study. To quantify the extent of lung involvement, each CXR image was given a score ([Blinded] score), ranging from 0 to 24, depending on the presence of reticular pattern and/or ground-glass opacities and/or extensive consolidations in each of the 12 areas in which the lungs were divided. The score was calculated by an expert radiologist, blinded to laboratory tests. The ability of the [Blinded] score to predict hospital admission and mortality, after adjusting for some variables (age; gender; comorbidities; time between symptoms onset and admission), using univariate and multivariate statistical analysis was investigated retrospectively. Results Among the 554 patients, 115 of which (21%) had a negative CXR, the in-hospital mortality was 16% (90/554). At univariate analysis, age, gender, and comorbidities were significant predictors of mortality and hospital admission. At multivariate analysis, adjusting for age and gender, the [Blinded] score was an independent predictor of mortality and hospitalisation. In particular, patients with a [Blinded] score ≥ 9 had a mortality risk five-times higher than those with a lower score. Other independent predictors of mortality were gender and age. Conclusions The CXR [Blinded] score was an independent predictive factor of both in-hospital mortality and hospital admission.

from 0 to 24, depending on the presence of reticular pattern and/or ground-glass opacities and/or extensive consolidations in each of the 12 areas in which the lungs were divided. The score was calculated by an expert radiologist, blinded to laboratory tests. The ability of the [Blinded] score to predict hospital admission and mortality, after adjusting for some variables (age; gender; comorbidities; time between symptoms onset and admission), using univariate and multivariate statistical analysis was investigated retrospectively. RESULTS: Among the 554 patients, 115 of which (21%) had a negative CXR, the inhospital mortality was 16% (90/554). At univariate analysis, age, gender, and comorbidities were significant predictors of mortality and hospital admission. At multivariate analysis, adjusting for age and gender, the [Blinded] score was an independent predictor of mortality and hospitalisation. In particular, patients with a

[Blinded] score ≥ 9 had a mortality risk five-times higher than those with a lower score. Other independent predictors of mortality were gender and age.

CONCLUSIONS: The CXR [Blinded] score was an independent predictive factor of both in-hospital mortality and hospital admission. The reference standard for the diagnosis of SARS-CoV-2 infection is a positive result of real-time reverse transcriptase polymerase chain reaction (RT-PCR) on nasooropharyngeal swab samples; however, chest imaging also plays a crucial role as an adjunct diagnostic tool, especially in settings where RT-PCR results are not readily available [1] [2] [3] [4] ; moreover, it may help guide decisions about patient management [1, 2, 4] . Computed tomography (CT) has proven to be more sensitive than chest radiography (CXR) in detecting imaging features of COVID-19 [5, 6] , but it carries several disadvantages (e.g., high costs; high risk of cross-infection; low specificity; availability). For these reasons, many radiological professional organisations have advised against the adoption of CT as a screening tool [3, 4, 7] , and have encouraged the use of portable CXR, which has become the primary imaging technique used for clinical management in different countries.

In our centre, one of the reference hospitals for COVID-19 in [Blinded], the diagnostic pathway includes a combination of clinical, laboratory, and imaging tests in association with RT-PCR; in particular, CXR is performed routinely, whereas chest CT is reserved for selected cases. This strategy allowed us to collect a large consecutive series of CXRs performed in symptomatic patients with suspected COVID-19.

Evidence on the diagnostic performance of CXR in diagnosing COVID-19 pneumonia is still limited and few reports described the usefulness of CXR severity scores [8] [9] [10] . Moreover, only two studies [9, 10] For all patients, only the first CXR acquired at admission was evaluated. All CXRs were acquired as digital radiograms following local protocols. In particular, CXRs were acquired in two projections (posteroanterior and laterolateral) when possible, and in one projection only (anteroposterior) in the case of seriously ill patients.

All CXRs were evaluated by a radiologist with >20 years of experience, blinded to the laboratory results and to the final outcomes, who classified CXR as positive or negative for COVID-19: according to the literature [11] [12] [13] [14] [15] . The main features considered as suggestive for COVID-19 were interstitial reticular pattern, groundglass opacities, and extensive consolidations, mostly involving the lower zones of both lungs with a preferred peripheral subpleural distribution (Fig. 1 ).

In order to evaluate the extension and distribution of disease, each lung was virtually divided into six areas (upper external, upper internal, middle external, middle internal, lower external, lower internal), for a total of 12 areas. Each area was given 0 points in case of no alterations, 1 point in case of interstitial reticular pattern or ground-glass opacities, and 2 points if extensive consolidations were observed; by summing the individual scores, a total score was obtained, ranging from 0 to 24

Categorical variables were reported as counts (percentages), whereas continuous variables were reported as mean (standard deviation) or median (interquartile range, IQR), as appropriate. The CXR [Blinded] score was categorised according to tertiles.

In order to assess the predictive accuracy of CXR [Blinded] score on the risk of the J o u r n a l P r e -p r o o f two outcomes (hospitalisation and death), a logistic regression approach was adopted. The following variables were considered for adjustment in statistical models: age (categorised in quartiles); gender; comorbidities (categorised as 0, 1, 2 or more); radiological pattern (negative; ground-glass opacities; interstitial reticular pattern; extensive consolidations); time from symptoms onset before ED admission (categorised as <7 or ≥7 days). First, univariate logistic models were fitted to assess the association between each of the potential predictors and the outcome. Then, a multivariate regression analysis was performed by including only the predictors that showed a significant effect at univariate analysis. A stepwise strategy was then adopted to identify the best multivariate model. Results of the logistic regression analysis were reported as odds ratios (OR) with their 95% confidence intervals (CI).

The predictive ability of the multivariate model was assessed calculating the cstatistic. Two-sided p-values <0.05 were considered statistically significant.

Statistical analyses were performed using SAS statistical software (release 9.4).

The patient flowchart is shown in Fig. 4 Table 2 ).

The relationship between in-hospital mortality and the mentioned predictors (age, gender, comorbidities, time between symptoms onset and admission, CXR pattern, CXR score) is summarised in Table 3 . 

[Blinded], a combination of clinical, laboratory, and imaging tests are used to triage patients with suspected COVID-19. Along with RT-PCR, whose results may be not readily available, especially during incidence peaks, all suspected patients undergo CXR, while chest CT is reserved for selected cases.

From the analysis of a large cohort of symptomatic patients with laboratoryconfirmed COVID-19, it was found that 80% had CXR abnormalities, a result consistent with other studies. Wong et al. [12] described CXR abnormalities in 69% of cases in a small cohort of 64 patients, while Vancheri et al. [16] reported the presence of pathological findings in as much as 75% of cases in a larger cohort of 240 patients. On the contrary, Toussie et al. [10] , evaluating 338 young and middleaged patients with COVID-19 pneumonia, found abnormalities at baseline CXR in 50% of cases, and Hui et al. [17] reported pathological findings in only 18% of patients. In the latter two studies, the lower percentage of positive CXRs might be explained by the earlier presentation of patients to the ED, with a median of 4 days J o u r n a l P r e -p r o o f between symptom onset and hospital admission, in contrast to 7 days in the present study: indeed, some authors described a correlation between disease severity and time from symptom onset [14, 15, 18] .

In a setting of high disease prevalence, the present results support the choice of using CXR instead of chest CT; in fact, the positivity of CXR, in combination with a clinical suspicion, does not justify the need for a chest CT.

As a main result of this study, the [Blinded] score, a novel easy to assess CXR severity score, was found to be an independent predictor of COVID19-related inhospital mortality. In particular, patients with a [Blinded] score ≥9 had a mortality rate five-times higher than those with a score ≤ 2.

The [Blinded] score, which considers six zones per lung, is a semiquantitative score that combines qualitative and quantitative features, as it is based on the extension of lung involvement and on the pattern of parenchymal abnormalities. In particular, the division between internal and peripheral lung areas reflects the typical distribution of lung abnormalities in COVID-19 pneumonia. Thanks to these features, the score has the potential to be more precise and informative than those focused on abnormalities extension alone [11] .

The role of the score in predicting mortality bears similarities to two recent reports, involving smaller cohorts (approx. 300 patients) [9, 10] : in particular, Borghesi et al. [9] found their CXR score to be predictive of in-hospital mortality, in association with patient age and immunosuppression. Their score, matching qualitative assessment of lung abnormalities with their extent, is similar to the [Blinded] score, but it splits each lung in three zones instead of six and assigns a score to lung abnormalities in a different way. Toussie et al. [10] , evaluating 334 young and middle-age adult patients, used a CXR score based on the presence of lung opacities in the three J o u r n a l P r e -p r o o f zones in which each lung was divided, finding it to be a good predictor of hospital admission and intubation. Some authors investigated the role of artificial intelligence (AI) applied to chest imaging in predicting clinical outcomes; in particular, Mushtaq et al. [19] recently described a predictive value for an AI-based score applied to the initial CXR and focused on density and extent of opacities.

The [Blinded] score also proved to be an independent predictor of the final decision to admit the patient to the hospital; the only other variable that emerged as an independent predictor of hospital admission at multivariate analysis was patient age.

This result supports the role of CXR in managing COVID-19 patients, especially decision-making regarding whether to hospitalise or discharge the patient with the instruction to self-quarantine at home. This has clinical and logistic implications, most notably when a surge in cases puts a strain on hospitals, overcrowding wards and Eds, and reducing bed availability, therefore making it even more important to be able to quickly and reliably distinguish those who need hospital care from those who can be treated conservatively at home. In this context, the presence of a prevalent extensive consolidations pattern and/or the evidence of an extended lung disease at CXR, which correspond to a higher [Blinded] score, can support the clinician in making this decision, which is particularly challenging in times of emergency.

Finally, the use of CXR in the diagnostic pathway has advantages in terms of low cost, availability, and low risk of spreading the infection to the radiology staff.

The present study has some limitations. Firstly, CXR positivity and severity might have influenced the clinical decision regarding ED admission or discharge, but it is only a part of the decision process, which is mainly guided by symptoms and respiratory function. Secondly, this study does not include an evaluation of the reproducibility of this novel score; this will be investigated in a separate study.

Finally, considering the strict relationship between symptom duration and CXR findings, the absence of data on symptom onset for 21% of patients is acknowledged as a limitation.

In conclusion, the CXR [Blinded] score was found to be an independent predictive factor of both in-hospital mortality and hospital admission versus quarantine at home. This result, also considering the diagnostic value of CXR, reinforces the pivotal role of chest radiography in the management of COVID-19 patients at triage. The same CXR is shown with superimposed segmentation of each lung into six areas and relative scores, for a total [Blinded] score = 3. This patient was sent home for quarantine after 6 days of hospital admission. (c) CXR of a 61-year-old male patient with diabetes mellitus and arterial hypertension who presented to the ED with fever, cough, and a pO 2 of 70 mmHg. The CXR shows extensive consolidations (black arrow) in the peripheral half of the lower zone of the right lung and focal ground-glass opacities in the middle zone (white arrows); reticular pattern is present in the peripheral portions of the middle-lower zones of the left lung (white arrowheads). (d) Superimposed score grid with a total [Blinded] score = 8. This patient was discharged after 29 days of hospitalisation.

Use of chest imaging in the diagnosis and management of COVID-19: a WHO rapid advice guide

A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic

Recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection

Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

An update on COVID-19 for the radiologist -a British society of Thoracic Imaging statement

Performance of radiologists in the evaluation of the chest radiography with the use of a "new software score" in coronavirus disease 2019 pneumonia suspected patients

Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy

Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19

Time course of lung changes at chest CT during recovery from Coronavirus disease 2019 (COVID-19)

Frequency and distribution of chest radiographic findings in patients positive for COVID-19

Chest X-ray in new coronavirus disease 2019 (COVID-19) infection: findings and correlation with clinical outcome

Diagnostic impact of bedside chest Xray features of 2019 novel coronavirus in the routine admission at the emergency department: case series from Lombardy region

Portable chest X-ray in coronavirus disease-19 (COVID-19): a pictorial review

Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms

Clinical utility of chest radiography for severe COVID-19

Chest CT findings in coronavirus disease 2019 (COVID-19): relationship to duration of infection

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697